Hepatitis C News

WASHINGTON — An accelerated, nationally organized plan to eliminate hepatitis C virus in the United States could save more than 90,000 lives and nearly $60 billion by 2050, according to a health economics expert at The Liver Meeting.

WASHINGTON — An expert panel of physicians, researchers and scientific advisers called upon The Liver Meeting attendees to support a proposed national HCV elimination program in the US.

WASHINGTON — Implementation of care re-engagement programs led to the treatment of more than 700 patients with untreated hepatitis C virus infection who had been lost to follow-up, according to research presented at The Liver Meeting.

WASHINGTON — Patients with alcohol use disorder and diabetes mellitus or hepatitis C were at higher risk for advanced liver disease, while African American race had a protective effect, according to late-breaking data at The Liver Meeting.

People with HIV and untreated hepatitis C virus have an 85% higher risk for type 1 MI per each 10-year increase in age, researchers reported.

An outbreak study based in West Virginia showed that people who inject drugs and have had hepatitis C are at risk for additional complications of injection drug use, including HIV hepatitis A and hepatitis B infection.

According to presented results, patients with hepatitis C who undergo total joint arthroplasty and are Childs-Pugh class B or C have increased 2-year mortality rates compared with patients who are Childs-Pugh class A.

Despite global declines in liver cancer mortality attributed to hepatitis B and C, liver cancer mortality rose sharply in the Americas, driven by an increase in nonalcoholic steatohepatitis, according to data published in Cell Metabolism.

New data from a CDC Vital Signs report show that less than one-third of people with hepatitis C receive treatment within 1 year of their diagnosis despite the availability of direct-acting antivirals.

The U.S. Public Health Service has published an updated recommendation for solid organ transplant candidates aged younger than 12 years, which now exempts them from testing for HIV and hepatitis B and C viruses during surgical admission.